{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:37Z","timestamp":1788225337303,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000346","name":"Ataxia UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["ST_009_20210728"],"award-info":[{"award-number":["ST_009_20210728"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.isci.2026.116479","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:50:18Z","timestamp":1782150618000},"page":"116479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of sphingolipid-metabolizing enzymes in Friedreich\u2019s ataxia: In vitro and in vivo insights into therapeutic targeting"],"prefix":"10.1016","volume":"29","author":[{"given":"Zenouska","family":"Ramchunder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Kalef-Ezra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqlain","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Jonathan","family":"Edzeamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Szunyogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Gittins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Castro Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wade-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamo","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charareh","family":"Pourzand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-780X","authenticated-orcid":false,"given":"Sara","family":"Anjomani Virmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116479_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.65.10.1296","article-title":"Friedreich ataxia","volume":"65","author":"Pandolfo","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.isci.2026.116479_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0887-8994(03)00004-3","article-title":"Friedreich\u2019s ataxia","volume":"28","author":"Alper","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.isci.2026.116479_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1359618","article-title":"Emerging antioxidant therapies in Friedreich's ataxia","volume":"15","author":"Edzeamey","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.116479_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.736253","article-title":"Friedreich's ataxia frequency in a large cohort of genetically undetermined ataxia patients","volume":"12","author":"Brown","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2026.116479_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.37.1.1","article-title":"Friedreich ataxia: an overview","volume":"37","author":"Delatycki","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.isci.2026.116479_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich's ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.isci.2026.116479_bib7","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2026.116479_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103402","article-title":"Promising tools into oxidative stress: a review of non-rodent model organisms","volume":"77","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.116479_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-99337-6","article-title":"Galleria mellonella as a drug discovery model to study oxidative stress","volume":"15","author":"Edzeamey","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116479_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16043","article-title":"Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1\/Mef2 activation, leading to neurodegeneration","volume":"5","author":"Chen","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116479_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20732","article-title":"Loss of Frataxin activates the iron\/sphingolipid\/PDK1\/Mef2 pathway in mammals","volume":"5","author":"Chen","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116479_bib12","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/120.12.2131","article-title":"Friedreich's ataxia. Revision of the phenotype according to molecular genetics","volume":"120","author":"Sch\u00f6ls","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.isci.2026.116479_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ana.23698","article-title":"Central role and mechanisms of \u03b2-cell dysfunction and death in friedreich ataxia\u2013associated diabetes","volume":"72","author":"Cnop","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2026.116479_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXie study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2026.116479_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fpls.2018.00751","article-title":"Glutathione S-transferases: role in combating abiotic stresses including arsenic detoxification in plants","volume":"9","author":"Kumar","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.isci.2026.116479_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2023.03.005","article-title":"Omaveloxolone (SkyclarysTM) for patients with Friedreich's ataxia","volume":"44","author":"Naidu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2026.116479_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13543784.2023.2173063","article-title":"Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia","volume":"32","author":"Profeta","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.isci.2026.116479_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.redox.2013.08.006","article-title":"Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells","volume":"1","author":"Steele","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.116479_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2025.2505303","article-title":"Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich\u2019s ataxia: insights from in vitro models","volume":"30","author":"Edzeamey","year":"2025","journal-title":"Redox Rep."},{"key":"10.1016\/j.isci.2026.116479_bib21","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2026.116479_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: an overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao","year":"2013","journal-title":"J. Lipids"},{"key":"10.1016\/j.isci.2026.116479_bib23","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s12035-018-1286-3","article-title":"The cross-talk between sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration","volume":"56","author":"J\u0119\u015bko","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2026.116479_bib24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.isci.2026.116479_bib25","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1194\/jlr.R058362","article-title":"Lipid phosphate phosphatases and their roles in mammalian physiology and pathology","volume":"56","author":"Tang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.isci.2026.116479_bib26","series-title":"Cross Talk between Ceramide and Redox Signaling: Implications for Endothelial Dysfunction and Renal Disease","first-page":"171","author":"Li","year":"2013"},{"key":"10.1016\/j.isci.2026.116479_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jb\/mvv030","article-title":"Nrf2 up-regulates the induction of acidic sphingomyelinase by electrophiles","volume":"158","author":"Kumagai","year":"2015","journal-title":"J. Biochem."},{"key":"10.1016\/j.isci.2026.116479_bib28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1159\/000495716","article-title":"K6PC-5 activates SphK1-Nrf2 signaling to protect neuronal cells from oxygen glucose deprivation\/re-oxygenation","volume":"51","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.isci.2026.116479_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111998","article-title":"Neurodegenerative disorders: Spotlight on sphingolipids","volume":"22","author":"Mandik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116479_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100255","article-title":"Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich\u2019s ataxia","volume":"63","author":"Wang","year":"2022","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.isci.2026.116479_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102266","article-title":"The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection","volume":"24","author":"Imre","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.116479_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fgene.2020.00584","article-title":"HMTase inhibitors as a potential epigenetic-based therapeutic approach for Friedreich's Ataxia","volume":"11","author":"Sherzai","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.isci.2026.116479_bib33","doi-asserted-by":"crossref","first-page":"43214","DOI":"10.1074\/jbc.M306709200","article-title":"Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity","volume":"278","author":"Smyth","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.116479_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron\u2013sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"R\u00f6tig","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116479_bib35","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1039\/c8mt00257f","article-title":"The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A","volume":"11","author":"Reelfs","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.isci.2026.116479_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10534-022-00383-8","article-title":"The synthesis and properties of mitochondrial targeted iron chelators","volume":"36","author":"Cilibrizzi","year":"2023","journal-title":"Biometals"},{"key":"10.1016\/j.isci.2026.116479_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2019.00075","article-title":"The role of iron in Friedreich\u2019s ataxia: insights from studies in human tissues and cellular and animal models","volume":"13","author":"Llorens","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2026.116479_bib38","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1093\/hmg\/ddu408","article-title":"Dyclonine rescue frataxin deficiency in animal models and buccal cells of patients with Friedreich\u2019s ataxia","volume":"23","author":"Sahdeo","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2026.116479_bib39","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2026.116479_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/15216540600871118","article-title":"Sphingosine and ceramide signalling in apoptosis","volume":"58","author":"Woodcock","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.isci.2026.116479_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217776","article-title":"Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia","volume":"14","author":"Jasoliya","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116479_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119031","article-title":"Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis","volume":"195","author":"Portillo-Carrasquer","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.116479_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s12276-024-01203-4","article-title":"Ceramide kinase-mediated C1P metabolism attenuates acute liver injury by inhibiting the interaction between KEAP1 and NRF2","volume":"56","author":"Dong","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.116479_bib44","article-title":"Pharmacological inhibition of sphingolipid synthesis reduced ferroptosis by stimulating the HIF-1 pathway","volume":"25","author":"Liu","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.116479_bib45","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1038\/s41598-022-08422-7","article-title":"Lipid phosphate phosphatase 3 in smooth muscle cells regulates angiotensin II-induced abdominal aortic aneurysm formation","volume":"12","author":"Van Hoose","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116479_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.958398","article-title":"Perspectives on current models of Friedreich's ataxia","volume":"10","author":"Kelek\u00e7i","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2026.116479_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101529","article-title":"Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes","volume":"40","author":"Li","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.isci.2026.116479_bib48","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1074\/jbc.M002759200","article-title":"Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.116479_bib49","doi-asserted-by":"crossref","first-page":"36898","DOI":"10.18632\/oncotarget.16370","article-title":"Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget","volume":"8","author":"Hatoum","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.116479_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027150","article-title":"Loss of sphingosine kinase 1\/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116479_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnmol.2015.00029","article-title":"Sphingosine kinase 2-deficiency mediated changes in spinal pain processing","volume":"8","author":"Canlas","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.isci.2026.116479_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2020.02.021","article-title":"Loss-or gain-of-function mutations in ACOX1 cause axonal loss via different mechanisms","volume":"106","author":"Chung","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2026.116479_bib53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cmet.2023.03.022","article-title":"Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation","volume":"35","author":"Chung","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.116479_bib54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2026.116479_bib55","first-page":"225","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich\u2019s ataxia","volume":"8","author":"Anjomani Virmouni","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.isci.2026.116479_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue of the Friedreich's ataxia knockout mouse by human YAC transgeneis","volume":"3","author":"Pook","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1016\/j.isci.2026.116479_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygeno.2004.04.003","article-title":"GAA repeat instability in Friedreich ataxia YAC transgenic mice","volume":"84","author":"Al-Mahdawi","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.isci.2026.116479_bib58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neruonal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.isci.2026.116479_bib59","article-title":"Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia","volume":"9","author":"Anjomani","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116479_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.930422","article-title":"A new FRDA mouse model [Fxn null: YG8s (GAA)> 800] with more than 800 GAA repeats","volume":"17","author":"Kalef-Ezra","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2026.116479_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114305","article-title":"Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology","volume":"299","author":"Suleman","year":"2022","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.isci.2026.116479_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2024.114884","article-title":"Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture","volume":"325","author":"Suleman","year":"2024","journal-title":"J. Virol. Methods"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:53:33Z","timestamp":1788224013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226018547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589004226018547"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116479","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of sphingolipid-metabolizing enzymes in Friedreich\u2019s ataxia: In vitro and in vivo insights into therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116479"}}